価格表

在庫・価格 : 2024年06月01日 20時39分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-AFP, Human/Mouse, Mouse-Mono(189502) <Anti-α Fetoprotein>
データシート※最新のデータシートでない場合があります
MAB1368 RSDアールアンドディー システムス
R&D Systems, Inc.
100 μg ¥103,000
(未発注)
追加

在庫・価格 : 2024年06月01日 20時39分 現在

Anti-AFP, Human/Mouse, Mouse-Mono(189502) <Anti-α Fetoprotein>

  • 商品コード:MAB1368
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥103,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sakaguchi T et al. Putative &quot;stemness&quot; gene jam-B is not required for maintenance of stem cell state in embryonic, neural, or hematopoietic stem cells. Mol. Cell. Biol. 2006 Sep;26(17):6557-70
Sakaguchi T et al
2006/01/01
Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue PubMed
2 Miyabayashi T et al. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U.S.A. 2007 Mar;104(13):5668-73
Miyabayashi T et al
2007/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
3 Castaneda JA et al. Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease. Neurobiol. Dis. 2008 Jan;29(1):92-102
Castaneda JA et al
2008/01/01
Species: Human, Mouse, Application: Western Blot, Sample type: purified AFP, Homogenized Tissue PubMed
4 Takahashi K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 Nov;131(5):861-72
Takahashi K et al
2007/01/01
Species: Human, Application: IHC, Sample type: Whole Cells PubMed
5 Rountree CB et al. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells 2009 Feb;27(2):290-9
Rountree CB et al
2009/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
6 Takenaka C et al. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp. Hematol. 2010 Feb;38(2):154-62
Takenaka C et al
2010/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
7 Oda Y et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 2010 Sep;285(38):29270-8
Oda Y et al
2010/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
8 Haraguchi N et al. CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest. 2010 Sep;120(9):3326-39
Haraguchi N et al
2010/01/01
Application: Functional Assay, Sample Type: Whole Cells PubMed
9 Li Z et al. Small RNA-mediated regulation of iPS cell generation. EMBO J. 2011 Mar;30(5):823-34
Li Z et al
2011/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
10 Jeon K et al. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev. 2012 Sep;21(14):2642-55
Jeon K et al
2012/01/01
Application: ICC, Sample Type: Whole Cells PubMed
11 Yagi T et al. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS ONE 2012;7(7):e41572
Yagi T et al
2012/01/01
Application: ICC, Sample Type: Whole Cells PubMed
12 Yamamizu K et al. Identification of transcription factors for lineage-specific ESC differentiation. Stem Cell Reports 2013;1(6):545-59
Yamamizu K et al
2013/01/01
Application: ICC, Sample Type: Whole Cells PubMed
13 Bershteyn M et al. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 2014 Mar;507(7490):99-103
Bershteyn M et al
2014/01/01
Application: ICC Fresh, Sample Type: Whole Cells PubMed
14 Yamasaki S et al. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-&#x392;1 regulation of pluripotency. PLoS ONE 2014;9(1):e87151
Yamasaki S et al
2014/01/01
Application: Immunocytochemistry, Sample Type: cell cultures PubMed
15 Ohnuma K et al. Enzyme-free passage of human pluripotent stem cells by controlling divalent cations. Sci Rep 2014;4:4646
Ohnuma K et al
2014/01/01
Application: IHC, Sample Type: Whole Cells PubMed
16 Nguyen LH et al. Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell 2014 Aug;26(2):248-61
Nguyen LH et al
2014/01/01
Application: Immunofluorescence, Sample Type: Whole Tissue PubMed
17 Obokata H et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014 Jan;505(7485):641-7
Obokata H et al
2014/01/01
Application: IHC Paraffin-embedded, Sample Type: tissue PubMed
18 Takenaka C et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE 2015;10(6):e0129855
Takenaka C et al
2015/01/01
Application: IHC Not Specified, Sample Type: Whole Cells PubMed
19 Kawaguchi T et al. Generation of Na&#xEF;ve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLoS ONE 2015;10(8):e0135403
Kawaguchi T et al
2015/01/01
Application: IHC Not Specified, Sample Type: Whole Cells PubMed
20 Bolnick JM et al. Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease. Sci Rep 2016 Sep;6:32382
Bolnick JM et al
2016/01/01
Application: IHC - Not specified, Sample Type: Whole Cells PubMed
21 Schmidt A et al. One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet. Int J Mol Sci 2017 Apr;18(4)
Schmidt A et al
2017/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
22 Tanaka Y et al. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem Cell Res 2018 Apr;28:100-104
Tanaka Y et al
2018/01/01
Species: Human, Applications: ICC PubMed
23 Higelin J et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res 2018 Jul;30:150-162
Higelin J et al
2018/01/01
Species: Human, Applications: ICC PubMed
24 Bolinches-Amor坦s A et al. Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene. Stem Cell Res 2018 Apr;28:96-99
Bolinches-Amor坦s A et al
2018/01/01
Species: Human, Applications: Flow PubMed
25 Merkert S et al. Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN. Stem Cell Res 2017 Aug;23:95-97
Merkert S et al
2017/01/01
Species: Human, Applications: ICC PubMed
26 Zhang J et al. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation. Cell Death Dis 2018 Feb;9(2):224
Zhang J et al
2018/01/01
Species: Mouse, Applications: ICC PubMed
27 de la Cerda B et al. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene. Stem Cell Res 2019 Apr;36:101426
de la Cerda B et al
2019/01/01
PubMed
28 Castelli A et al. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells. Stem Cells 2019 Jul;37(7):876-887
Castelli A et al
2019/01/01
PubMed
29 Gao X et al. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel. Stem Cell Res 2018 Aug;31:193-196
Gao X et al
2018/01/01
PubMed
30 Hiramoto T et al. Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells. Mol Ther 2020 01;28(1):129-141
Hiramoto T et al
2020/01/01
PubMed
31 D鱈az-Guerra E et al. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer&quot;s disease patient carrying the PSEN1-G206D mutation. Stem Cell Res 2019 10;40:101574
D鱈az-Guerra E et al
2019/01/01
PubMed
32 Rodr鱈guez-Traver E et al. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson&quot;s disease patient carrying the L444P mutation in the GBA1 gene. Stem Cell Res 2019 10;40:101578
Rodr鱈guez-Traver E et al
2019/01/01
PubMed
33 Fuchs NV et al. Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Res 2019 12;41:101592
Fuchs NV et al
2019/01/01
PubMed
34 D鱈az-Guerra E et al. An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer&quot;s disease patient with the APOE-&#x3B5;4/&#x3B5;4 alleles. Stem Cell Res 2019 12;41:101588
D鱈az-Guerra E et al
2019/01/01
PubMed
35 Ma XH et al. Development and <i>in vitro</i> study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World J Gastroenterol 2019 Jun;25(24):3030-3043
Ma XH et al
2019/01/01
PubMed
36 Kamand M et al. Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem Cell Res 2020 07;46:101834
Kamand M et al
2020/01/01
PubMed
37 Rodr鱈guez-Traver E et al. A collection of three integration-free iPSCs derived from old male and female healthy subjects. Stem Cell Res 2020 01;42:101663
Rodr鱈guez-Traver E et al
2020/01/01
PubMed
38 Haake K et al. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis. Stem Cell Res 2020 03;43:101713
Haake K et al
2020/01/01
PubMed
39 Fuchs NV et al. Induced pluripotent stem cell line (PEIi003-A) derived from an apparently healthy male individual. Stem Cell Res 2020 01;42:101679
Fuchs NV et al
2020/01/01
PubMed
40 Pongpamorn P et al. Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G&gt;A) mutation in the TGFBR1 gene. Stem Cell Res 2020 03;43:10170
Pongpamorn P et al
2020/01/01
Species: Human, Applications: Flow Cytometry PubMed
41 Fuchs NV et al. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Gouti&#xE8;res syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). Stem Cell Re
Fuchs NV et al
2020/01/01
Species: Human, Applications: ICC PubMed
42 Haase A et al. Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives. Stem Cell Res 2021 04;52:102206
Haase A et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
43 Takahashi K et al. Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells. Cell Rep 2020 06;31(9):107715
Takahashi K et al
2020/01/01
Species: Human, Applications: ICC PubMed
44 Ca単ibano-Hern叩ndez A et al. Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene. Stem Cell Res 2021 05;53:102301
Ca単ibano-Hern叩ndez A et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
45 Jamil MA et al. Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells. Int J Mol Sci 2020 Oct;21(20)
Jamil MA et al
2020/01/01
Species: Human, Applications: ICC PubMed
46 Kamand M et al. Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem Cell Res 2020 10;48:101974
Kamand M et al
2020/01/01
Species: Human, Applications: ICC PubMed
47 Ovechkina VS et al. Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A. Stem Cell Res 2020 10;48:101938
Ovechkina VS et al
2020/01/01
Species: Human, Applications: ICC PubMed
48 Jin L et al. STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells. Nat Commun 2020 11;11(1):5941
Jin L et al
2020/01/01
Species: Mouse, Applications: IHC PubMed
49 Geuder J et al. A non-invasive method to generate induced pluripotent stem cells from primate urine. Sci Rep 2021 Feb;11(1):3516
Geuder J et al
2021/01/01
Species: Human, Applications: ICC PubMed
50 Merkert S et al. Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing. Stem Cell Res 2020 Dec;50:102135
Merkert S et al
2020/01/01
Species: Human, Applications: Flow Cytometry PubMed
51 Li YP et al. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation. Stem Cell Res 2020 12;49:102075
Li YP et al
2020/01/01
Species: Human, Applications: ICC PubMed
  • No.: 1
  • 文献情報:
    Sakaguchi T et al. Putative &quot;stemness&quot; gene jam-B is not required for maintenance of stem cell state in embryonic, neural, or hematopoietic stem cells. Mol. Cell. Biol. 2006 Sep;26(17):6557-70
    Sakaguchi T et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Miyabayashi T et al. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U.S.A. 2007 Mar;104(13):5668-73
    Miyabayashi T et al
    2007/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Castaneda JA et al. Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease. Neurobiol. Dis. 2008 Jan;29(1):92-102
    Castaneda JA et al
    2008/01/01
  • 備考:
    Species: Human, Mouse, Application: Western Blot, Sample type: purified AFP, Homogenized Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Takahashi K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 Nov;131(5):861-72
    Takahashi K et al
    2007/01/01
  • 備考:
    Species: Human, Application: IHC, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Rountree CB et al. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells 2009 Feb;27(2):290-9
    Rountree CB et al
    2009/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Takenaka C et al. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp. Hematol. 2010 Feb;38(2):154-62
    Takenaka C et al
    2010/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Oda Y et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 2010 Sep;285(38):29270-8
    Oda Y et al
    2010/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Haraguchi N et al. CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest. 2010 Sep;120(9):3326-39
    Haraguchi N et al
    2010/01/01
  • 備考:
    Application: Functional Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Li Z et al. Small RNA-mediated regulation of iPS cell generation. EMBO J. 2011 Mar;30(5):823-34
    Li Z et al
    2011/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Jeon K et al. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev. 2012 Sep;21(14):2642-55
    Jeon K et al
    2012/01/01
  • 備考:
    Application: ICC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yagi T et al. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS ONE 2012;7(7):e41572
    Yagi T et al
    2012/01/01
  • 備考:
    Application: ICC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Yamamizu K et al. Identification of transcription factors for lineage-specific ESC differentiation. Stem Cell Reports 2013;1(6):545-59
    Yamamizu K et al
    2013/01/01
  • 備考:
    Application: ICC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Bershteyn M et al. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 2014 Mar;507(7490):99-103
    Bershteyn M et al
    2014/01/01
  • 備考:
    Application: ICC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Yamasaki S et al. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-&#x392;1 regulation of pluripotency. PLoS ONE 2014;9(1):e87151
    Yamasaki S et al
    2014/01/01
  • 備考:
    Application: Immunocytochemistry, Sample Type: cell cultures
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Ohnuma K et al. Enzyme-free passage of human pluripotent stem cells by controlling divalent cations. Sci Rep 2014;4:4646
    Ohnuma K et al
    2014/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Nguyen LH et al. Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell 2014 Aug;26(2):248-61
    Nguyen LH et al
    2014/01/01
  • 備考:
    Application: Immunofluorescence, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Obokata H et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014 Jan;505(7485):641-7
    Obokata H et al
    2014/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: tissue
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Takenaka C et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE 2015;10(6):e0129855
    Takenaka C et al
    2015/01/01
  • 備考:
    Application: IHC Not Specified, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kawaguchi T et al. Generation of Na&#xEF;ve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLoS ONE 2015;10(8):e0135403
    Kawaguchi T et al
    2015/01/01
  • 備考:
    Application: IHC Not Specified, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Bolnick JM et al. Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease. Sci Rep 2016 Sep;6:32382
    Bolnick JM et al
    2016/01/01
  • 備考:
    Application: IHC - Not specified, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Schmidt A et al. One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet. Int J Mol Sci 2017 Apr;18(4)
    Schmidt A et al
    2017/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Tanaka Y et al. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem Cell Res 2018 Apr;28:100-104
    Tanaka Y et al
    2018/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Higelin J et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res 2018 Jul;30:150-162
    Higelin J et al
    2018/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Bolinches-Amor坦s A et al. Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene. Stem Cell Res 2018 Apr;28:96-99
    Bolinches-Amor坦s A et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Flow
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Merkert S et al. Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN. Stem Cell Res 2017 Aug;23:95-97
    Merkert S et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Zhang J et al. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation. Cell Death Dis 2018 Feb;9(2):224
    Zhang J et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: ICC
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    de la Cerda B et al. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene. Stem Cell Res 2019 Apr;36:101426
    de la Cerda B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Castelli A et al. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells. Stem Cells 2019 Jul;37(7):876-887
    Castelli A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Gao X et al. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel. Stem Cell Res 2018 Aug;31:193-196
    Gao X et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Hiramoto T et al. Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells. Mol Ther 2020 01;28(1):129-141
    Hiramoto T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    D鱈az-Guerra E et al. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer&quot;s disease patient carrying the PSEN1-G206D mutation. Stem Cell Res 2019 10;40:101574
    D鱈az-Guerra E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Rodr鱈guez-Traver E et al. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson&quot;s disease patient carrying the L444P mutation in the GBA1 gene. Stem Cell Res 2019 10;40:101578
    Rodr鱈guez-Traver E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Fuchs NV et al. Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Res 2019 12;41:101592
    Fuchs NV et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    D鱈az-Guerra E et al. An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer&quot;s disease patient with the APOE-&#x3B5;4/&#x3B5;4 alleles. Stem Cell Res 2019 12;41:101588
    D鱈az-Guerra E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Ma XH et al. Development and <i>in vitro</i> study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World J Gastroenterol 2019 Jun;25(24):3030-3043
    Ma XH et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Kamand M et al. Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem Cell Res 2020 07;46:101834
    Kamand M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Rodr鱈guez-Traver E et al. A collection of three integration-free iPSCs derived from old male and female healthy subjects. Stem Cell Res 2020 01;42:101663
    Rodr鱈guez-Traver E et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Haake K et al. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis. Stem Cell Res 2020 03;43:101713
    Haake K et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Fuchs NV et al. Induced pluripotent stem cell line (PEIi003-A) derived from an apparently healthy male individual. Stem Cell Res 2020 01;42:101679
    Fuchs NV et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Pongpamorn P et al. Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G&gt;A) mutation in the TGFBR1 gene. Stem Cell Res 2020 03;43:10170
    Pongpamorn P et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Fuchs NV et al. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Gouti&#xE8;res syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). Stem Cell Re
    Fuchs NV et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Haase A et al. Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives. Stem Cell Res 2021 04;52:102206
    Haase A et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Takahashi K et al. Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells. Cell Rep 2020 06;31(9):107715
    Takahashi K et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Ca単ibano-Hern叩ndez A et al. Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene. Stem Cell Res 2021 05;53:102301
    Ca単ibano-Hern叩ndez A et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Jamil MA et al. Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells. Int J Mol Sci 2020 Oct;21(20)
    Jamil MA et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Kamand M et al. Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem Cell Res 2020 10;48:101974
    Kamand M et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Ovechkina VS et al. Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A. Stem Cell Res 2020 10;48:101938
    Ovechkina VS et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Jin L et al. STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells. Nat Commun 2020 11;11(1):5941
    Jin L et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Geuder J et al. A non-invasive method to generate induced pluripotent stem cells from primate urine. Sci Rep 2021 Feb;11(1):3516
    Geuder J et al
    2021/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Merkert S et al. Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing. Stem Cell Res 2020 Dec;50:102135
    Merkert S et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Li YP et al. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation. Stem Cell Res 2020 12;49:102075
    Li YP et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed